Texas H&S §481.1122 Possession of Penalty Group 1-B (Fentanyl)

Statutory elements — § 481.1122

Texas Health & Safety Code § 481.1122 provides that, except as authorized by Chapter 481, a person commits an offense if the person knowingly or intentionally possesses a controlled substance listed in Penalty Group 1-B, unless the person obtained the substance directly from or under a valid prescription or order of a practitioner acting in the course of professional practice.

"Knowingly or intentionally" mens rea. Penal Code § 6.03(a)-(b) governs. The defendant must intend the possession or know the substance is in their possession. As with other Chapter 481 offenses, identification of the specific substance is not required — but knowledge that the substance is a controlled substance is. The mens rea analysis becomes particularly interesting in counterfeit-pill cases discussed below.

"Possesses." Penal Code § 1.07(a)(39) — actual or constructive possession. The affirmative-links framework applies; fentanyl cases frequently involve packages, vehicles, jointly occupied residences, and group settings with constructive-possession issues.

"Controlled substance" and Penalty Group 1-B. § 481.002(5) defines controlled substance to include adulterants and dilutants. § 481.1023 lists Penalty Group 1-B — primarily fentanyl, fentanyl analogs, and related synthetic opioids. The schedule includes acetylfentanyl, carfentanil, sufentanil, alfentanil, remifentanil, and other compounds identified by chemical name. Additional substances are added by amendment and administrative scheduling as new synthetic opioids enter the illicit market.

Prescription exception. Fentanyl is a legitimately prescribed medication (Duragesic patches, Sublimaze IV, Actiq lollipops, Subsys spray, and others) for severe pain management. Defendants in possession of legitimately prescribed fentanyl in original packaging fall within the prescription exception. The exception does not apply to illicit-market fentanyl, fentanyl outside the original prescription, or fentanyl obtained outside lawful authority. Healthcare-worker diversion cases are particularly common in PG 1-B prosecutions.

Affirmative defenses. § 481.062 provides limited registration defenses for authorized handlers (researchers, manufacturers, distributors). The narrow defense applies only when the handler operates within registration scope.

Penalty Group 1-B — what is in it

Penalty Group 1-B under § 481.1023 is a focused schedule centered on fentanyl and related synthetic opioids. The legislature created the separate schedule in 2017 to enable enhanced penalty structures for the substances driving the overdose crisis.

Fentanyl. The primary substance. Fentanyl is a synthetic opioid roughly 50-100 times more potent than morphine. Manufactured legitimately for medical use (severe pain management, anesthesia adjuncts) and increasingly produced illicitly in clandestine labs primarily outside the United States and imported into Texas through various distribution channels. Most illicit fentanyl in Texas markets is mixed with other substances or pressed into counterfeit prescription-style pills.

Fentanyl analogs. Carfentanil (used as an elephant tranquilizer; roughly 10,000 times more potent than morphine), acetylfentanyl, sufentanil, alfentanil, remifentanil, and a growing list of "designer" fentanyl analogs developed to circumvent existing scheduling. The legislature has progressively added analog substances as new ones appear in the illicit market.

The "analog" reach. § 481.106 controlled-substance analog framework applies to fentanyl-class substances — the state can prosecute newly-developed synthetic opioids before individual scheduling if structural and pharmacological similarity to scheduled substances can be proven.

The counterfeit-pill problem. The most consequential modern issue in PG 1-B cases. Illicit fentanyl is frequently pressed into pills designed to resemble legitimate prescription substances — counterfeit Xanax, counterfeit Adderall, counterfeit oxycodone (M30 pills), counterfeit Percocet. The actual substance is fentanyl, but the appearance suggests a different controlled substance. Defendants frequently possess what they believe is a less-controlled substance (PG 3 or PG 1) and are prosecuted at the substantially higher PG 1-B level based on the actual chemistry.

Distinction from PG 1. The principal substantive distinction is the enhanced penalty structure. Fentanyl is chemically a Penalty-Group-1-style substance, but the legislature created PG 1-B specifically to apply enhanced penalties. The same conduct that would produce a state jail felony in PG 1 produces a third-degree felony in PG 1-B; the same conduct that would be third-degree in PG 1 is second-degree in PG 1-B; and so on.

Weight tiers — one level higher than PG 1

§ 481.1122(b)-(f) sets five weight tiers, each one level higher than the corresponding PG 1 tier.

§ 481.1122(b) — Less than 1 gram. Third-degree felony under Penal Code § 12.34. Punishment range: 2 to 10 years TDCJ plus a fine up to $10,000. Note: this is two levels higher than PG 1's state-jail-felony floor for the same weight. A user-quantity fentanyl case starts as a third-degree felony.

§ 481.1122(c) — 1 gram or more but less than 4 grams. Second-degree felony under § 12.33. Punishment range: 2 to 20 years TDCJ plus a fine up to $10,000.

§ 481.1122(d) — 4 grams or more but less than 200 grams. First-degree felony under § 12.32. Punishment range: 5 to 99 years or life TDCJ plus a fine up to $10,000.

§ 481.1122(e) — 200 grams or more but less than 400 grams. First-degree felony with enhanced range. Punishment range: 10 to 99 years or life TDCJ plus a fine up to $100,000.

§ 481.1122(f) — 400 grams or more. First-degree felony with the most enhanced range. Punishment range: 15 to 99 years or life TDCJ plus a fine up to $250,000.

Aggregation rule under § 481.002(5). The aggregation rule applies — total mixture weight, including adulterants and dilutants. This is particularly consequential in PG 1-B cases because fentanyl is typically present at very low concentrations in the actual product. A typical illicit fentanyl pill contains 0.5 to 2 milligrams of fentanyl in a 100-200-milligram pill; the weight is the entire pill, not the active fentanyl content. A bag of "fentanyl-laced heroin" is weighed at total mixture weight.

Counterfeit-pill aggregation example. A defendant in possession of 200 counterfeit M30 pills, each weighing 100 milligrams (about 20 grams total), with each pill containing 1 milligram of fentanyl (200 milligrams total active fentanyl), is prosecuted at the 4-to-200-gram first-degree-felony tier. The active fentanyl is well under 1 gram, but the aggregate weight is 20 grams. The aggregation rule moves the case from a third-degree felony exposure (if measured by active fentanyl) to a first-degree felony exposure.

Drug-free zone enhancement. § 481.134 zone enhancement applies, moving each tier up by one level. A third-degree felony in a zone becomes a second-degree; a first-degree becomes the enhanced 10-to-99 range.

The fentanyl-caused-death murder enhancement

In 2023 the Texas legislature enacted HB 6 amending Penal Code § 19.02 (Murder) to add a fentanyl-caused-death enhancement. The provision allows a person who manufactures, delivers, or possesses with intent to deliver fentanyl that causes the death of another person to be charged with murder — a first-degree felony with a 5-99-year-or-life range — without requiring proof of the traditional murder mens rea elements.

Penal Code § 19.02(b)(1) felony-murder application. The statute uses the felony-murder framework. A person commits murder if the person commits or attempts to commit a felony, other than manslaughter, and in the course of and in furtherance of the commission or attempt, or in immediate flight from the commission or attempt, the person commits or attempts to commit an act clearly dangerous to human life that causes the death of an individual.

Application to fentanyl distribution. Manufacture or delivery of fentanyl is a felony under § 481.1123. Distribution that causes a death through overdose can be charged as felony murder under § 19.02(b)(3) with fentanyl delivery as the predicate felony. The state must prove the fentanyl was the cause of death and that the defendant's delivery was an "act clearly dangerous to human life."

The causation element. Defense counsel can contest the causation element in many cases. Overdose deaths frequently involve multiple substances (fentanyl combined with alcohol, benzodiazepines, cocaine, or other substances). Medical-examiner toxicology reports identifying multiple substances support causation defenses. Where the cause of death is genuinely ambiguous or where the defendant's delivery cannot be linked to the substance that caused the death, the murder enhancement is contestable.

The "act clearly dangerous to human life" element. The state must prove the delivery was clearly dangerous. The pharmacological character of fentanyl makes this element relatively easy to prove in pure-fentanyl cases. Counterfeit-pill cases — where the defendant believed they were delivering a different substance — present more genuine litigation on this element.

Federal parallel. Federal law has a "death enhancement" under 21 U.S.C. § 841(b)(1)(C) for drug distribution that results in death — a 20-year mandatory minimum. State-federal coordination matters when both sovereigns have charging interest.

Defense priority. The murder enhancement converts a delivery case into a murder case. Counsel selected immediately on a fatal-overdose investigation has substantial work on causation, distribution-link, and alternative-source analysis.

How these cases actually arise

Texas § 481.1122 prosecutions follow recognizable patterns shaped by the fentanyl market.

Counterfeit-pill arrests. The largest category. Defendants in possession of pills that visually resemble prescription Xanax, Adderall, oxycodone (M30s), or Percocet. The pills are recovered during traffic stops, search warrants, or post-overdose investigations. Laboratory analysis confirms fentanyl as the actual active substance. The mens rea and possession analysis become the central defense issues.

Fentanyl-laced heroin and cocaine cases. Defendants in possession of substances they believed were heroin, cocaine, or methamphetamine but which test positive for fentanyl (as a primary substance or as a fentanyl-laced mixture). The mens rea analysis is interesting — the defendant intended to possess a Penalty Group 1 substance but actually possessed a Penalty Group 1-B substance with substantially higher penalty exposure.

Overdose-investigation cases. Investigations triggered by overdose deaths or non-fatal overdose hospitalizations. Law enforcement traces the source of the fentanyl backward — phone records, controlled-buy operations, surveillance of suspected distributors. These cases frequently produce both standalone possession/delivery charges and fentanyl-caused-death murder enhancements where the chain to the deceased is established.

Mail and parcel interception. Fentanyl is increasingly shipped through commercial parcel services. Customs and Border Protection, the US Postal Inspection Service, and DEA task forces routinely intercept fentanyl shipments. Controlled-delivery operations to the addressee produce arrests at the moment of delivery. State and federal charging coordination is decided at the investigative stage.

Healthcare-worker diversion cases. Hospital nurses, anesthesiologists, and other healthcare workers with access to legitimate fentanyl (Duragesic patches, Sublimaze, surgical-anesthesia stocks) sometimes divert fentanyl from their workplace. Cases parallel licensing-board proceedings and Drug Enforcement Administration registration actions.

School and youth-context cases. Fentanyl-laced pills in school settings have produced highly publicized prosecutions. Drug-free zone enhancements apply automatically. Public attention and prosecutor enthusiasm both run high in these cases.

Border-interdiction and corridor cases. Fentanyl is increasingly produced in Mexico and trafficked through Texas. Drug interdiction along I-35, I-10, I-45, and US-59 corridors produces both state and federal prosecutions. Bulk-quantity cases (hundreds of pills, kilogram quantities) typically attract federal interest.

Defense strategy — suppression, identification, mens rea

The defense template for § 481.1122 cases has the standard four levers plus PG 1-B-specific dimensions.

Fourth Amendment suppression. Standard framework. Traffic-stop scope, search-warrant probable cause, consent voluntariness, K-9 alert reliability. Fentanyl cases often have aggressive law-enforcement responses (raid-style executions, immediate seizure of large pill quantities) that produce reviewable Fourth Amendment issues.

Substance identification. The state must prove the substance is fentanyl or a PG 1-B substance. Identification is established through GC-MS analysis. Fentanyl identification in pill form is generally reliable; identification in mixture cases (laced powders, residue, traces) is sometimes more contestable. The specific fentanyl analog identified can affect schedule placement and analog-prosecution defenses.

Mens rea in counterfeit-pill cases. The unique-to-PG-1-B issue. Where the defendant possessed a pill that visually resembled a less-controlled substance (counterfeit Xanax, counterfeit Adderall, counterfeit oxycodone), the defense can attack the mens rea element — the defendant intended to possess a less-controlled substance and did not know the pill contained fentanyl. Texas law does not categorically require the state to prove specific-substance knowledge, but the mens rea framing affects sentencing and prosecutorial discretion. Defense counsel should preserve and develop the mens rea argument explicitly.

Possession element. Standard affirmative-links framework. PG 1-B cases involving shared spaces (vehicles, residences, group settings) produce routine constructive-possession issues.

Weight challenges and aggregation. The aggregation rule consequence is severe in fentanyl cases. Defense counsel should examine the lab weighing methodology, the active-substance versus total-mixture analysis, and any tier-boundary opportunities. Where the case is at a tier boundary, small weight differences can shift the felony level dramatically.

Murder enhancement defense. In fatal-overdose investigations, the murder enhancement requires causation proof. Defense priorities: alternative-substance analysis (multiple substances in toxicology), alternative-source analysis (other suppliers in the deceased's contact network), distribution-link analysis (whether the defendant's specific delivery can be tied to the substance that caused death).

Federal-state coordination. Federal prosecution under 21 U.S.C. § 841(b)(1)(B) carries mandatory minimums (5 years for 40+ grams of fentanyl, 10 years for 400+ grams). State-federal forum decisions are made at the investigative stage. The 2023 state-law enhancements have narrowed the federal-vs-state penalty differential in some configurations, but federal exposure typically remains higher.

Pretrial release. PG 1-B pretrial release is meaningfully harder than other drug cases. Federal Bail Reform Act presumption applies in federal court; aggressive state detention contests are routine. Prepare for both from day one.

First 30 days — what to do, in order

Days 1–3. Retain counsel before any further interview. PG 1-B cases produce aggressive law-enforcement investigation including post-arrest interviews, family contact, and "cooperation" overtures. Custodial statements are recorded and discoverable. Counsel arranges pretrial release (often contested in PG 1-B cases), evaluates bond conditions, and instructs the defendant on no-statement obligations. For fatal-overdose investigations, counsel coordinates with any family or related parties to ensure consistent posture.

Days 3–10. Counsel issues preservation letters for body camera, dashcam, search-warrant records, and any third-party surveillance evidence. For fatal-overdose investigations, counsel obtains the medical-examiner toxicology report, ER and EMS records, and any toxicology evidence from the deceased's prior medical history. For counterfeit-pill cases, counsel obtains pill examples from any retail purchases or shipped packages to support the mens rea defense.

Days 10–20. Counsel requests the offense report, the laboratory analysis report (substance identification and concentration), the search-warrant documentation, and any communications evidence. The substance identification, the weight measurement, and the tier-boundary analysis are reviewed against the charging level. For murder-enhancement cases, the causation analysis is the dominant defense work. For counterfeit-pill cases, the mens rea posture is developed.

Days 20–30. Counsel evaluates the federal-state coordination posture and the forum decision. For cases where federal interest is active, federal counsel coordination is essential. Counsel opens dialogue with the state prosecutor on charging configuration. For murder-enhancement cases, the operative ask is removal of the enhancement or reduction to standard possession or delivery charges. For pure-possession cases, charging-level analysis (PG 1-B vs PG 1 in counterfeit-pill mens rea cases) is the principal negotiation lever.

PG 1-B cases are time-sensitive in ways other drug cases are not. The 2023 state-law enhancements, the federal task-force interest, and the public-attention dynamics around fentanyl produce compressed prosecution timelines and aggressive charging postures. Counsel selected on day three has substantially more to work with than counsel selected on day ninety.